The European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe release the latest data on the HIV epidemic in the European Region, marking the 30th anniversary of World AIDS Day.
A new candidate HIV vaccine from Scripps Research surmounts technical hurdles that stymied previous vaccine efforts, and stimulates a powerful anti-HIV antibody response in animal tests.
The abundance of personal smartphones in southern African countries got University of Washington professor Sarah Gimbel thinking: What if these phones were used by front-line health workers -- namely nurses -- to collect and analyze data on patients living with HIV or AIDS to improve their care?
A majority of the HIV-infected cells that persist in HIV-infected individuals even during suppressive antiretroviral therapy (ART) originated from cellular proliferation, not viral replication, according to new research published in Nature Communications.
The management of human immunodeficiency virus 1 (HIV), an autoimmune disorder that cripples the immune system by attacking healthy cells, remains a major global health challenge in developing countries that lack infrastructure and trained medical professionals.
A new study identified a significant association between HIV infection and complexities of treating patients with tuberculosis co-infection.
Infants born to HIV-positive mothers had high rates of congenital cytomegalovirus (CMV). Infants who also were infected before birth by the virus that causes AIDS were especially prone to CMV infection.
A Systemic Review from the Centers for Disease Control and Prevention analyzed studies of HIV-related stigma among healthcare provider and identified three main themes: attitudes, beliefs, and behaviors; quality of patient care; and education and training.
A persistent challenge in HIV/AIDS treatment and prevention is medication adherence – getting patients to take their medication as required to get the best results.
Research by a multi-institutional team, including two members from the University of Delaware, has revealed new details about the HIV virus capsid structure and how it develops.
A capsid is a protein shell that encloses a virus's genetic blueprint.